Eli Lilly is expected to launch its own potent oral candidate, orforglipron, in early 2026, and Novo Nordisk has recently expanded its oral Wegovy offerings
Its not positioned as a cure, but rather as a supportive element in a broader gut health strategy that includes whole foods, hydration, and mindfulness around inflammation triggers
As always, be sure to consult your healthcare professional and ask for more information on the possible risks or side effects associated with glutathione intake before starting any new treatments
RFX6 regulates human intestinal patterning and function upstream of PDX1
Acknowledgements This research was partially supported by NSF grants DMS-0616710(MR, HFN) and EF-1038593(HFN, MR) and NIH grant R01 ES019876 (D